Chugai Pharmaceutical Statistics

Total Valuation

CHGCF has a market cap or net worth of 105.93 billion. The enterprise value is 99.72 billion.

Market Cap	105.93B
Enterprise Value	99.72B

Important Dates

The next estimated earnings date is Friday, April 24, 2026.

Earnings Date	Apr 24, 2026
Ex-Dividend Date	Dec 29, 2025

Share Statistics

Current Share Class	1.65B
Shares Outstanding	n/a
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	18.87%
Float	639.83M

Valuation Ratios

The trailing PE ratio is 38.27.

PE Ratio	38.27
Forward PE	n/a
PS Ratio	13.20
PB Ratio	8.20
P/TBV Ratio	8.43
P/FCF Ratio	53.58
P/OCF Ratio	43.00
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.24, with an EV/FCF ratio of 50.43.

EV / Earnings	36.02
EV / Sales	12.49
EV / EBITDA	25.24
EV / EBIT	26.63
EV / FCF	50.43

Financial Position

The company has a current ratio of 4.23

Current Ratio	4.23
Quick Ratio	3.46
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	2,850.85

Financial Efficiency

Return on equity (ROE) is 22.10% and return on invested capital (ROIC) is 41.72%.

Return on Equity (ROE)	22.10%
Return on Assets (ROA)	15.77%
Return on Invested Capital (ROIC)	41.72%
Return on Capital Employed (ROCE)	28.68%
Weighted Average Cost of Capital (WACC)	6.43%
Revenue Per Employee	1.60M
Profits Per Employee	550,765
Employee Count	7,872
Asset Turnover	0.54
Inventory Turnover	1.41

Taxes

In the past 12 months, CHGCF has paid 1.04 billion in taxes.

Income Tax	1.04B
Effective Tax Rate	27.40%

Stock Price Statistics

The stock price has increased by +31.92% in the last 52 weeks. The beta is 0.40, so CHGCF's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	+31.92%
50-Day Moving Average	56.46
200-Day Moving Average	50.84
Relative Strength Index (RSI)	65.66
Average Volume (20 Days)	1,520

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CHGCF had revenue of 8.02 billion and earned 2.77 billion in profits. Earnings per share was 1.68.

Revenue	8.02B
Gross Profit	5.70B
Operating Income	3.76B
Pretax Income	3.81B
Net Income	2.77B
EBITDA	3.93B
EBIT	3.76B
Earnings Per Share (EPS)	1.68

Full Income Statement

Balance Sheet

The company has 6.25 billion in cash and n/a in debt, giving a net cash position of 6.25 billion.

Cash & Cash Equivalents	6.25B
Total Debt	n/a
Net Cash	6.25B
Net Cash Per Share	n/a
Equity (Book Value)	12.92B
Book Value Per Share	7.85
Working Capital	8.48B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.46 billion and capital expenditures -486.47 million, giving a free cash flow of 1.98 billion.

Operating Cash Flow	2.46B
Capital Expenditures	-486.47M
Free Cash Flow	1.98B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 71.09%, with operating and profit margins of 46.91% and 34.50%.

Gross Margin	71.09%
Operating Margin	46.91%
Pretax Margin	47.52%
Profit Margin	34.50%
EBITDA Margin	49.02%
EBIT Margin	46.91%
FCF Margin	24.64%

Dividends & Yields

This stock pays an annual dividend of 1.81, which amounts to a dividend yield of 2.79%.

Dividend Per Share	1.81
Dividend Yield	2.79%
Dividend Growth (YoY)	192.50%
Years of Dividend Growth	2
Payout Ratio	68.99%
Buyback Yield	-0.01%
Shareholder Yield	2.78%
Earnings Yield	2.61%
FCF Yield	1.87%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CHGCF has an Altman Z-Score of 19.16 and a Piotroski F-Score of 4.

Altman Z-Score	19.16
Piotroski F-Score	4